Missouri House Bill HB2427

Missouri 2022 Regular Session

• Introduced: 1/12/22
• Refer: 5/13/22

Caption

Creates provisions relating to insurance coverage for diagnostic examinations for breast cancer

Impact

If enacted, HB 2427 would amend existing state insurance laws to include comprehensive coverage for diagnostic examinations associated with breast cancer. This change is expected to alleviate financial burdens on patients who might otherwise hesitate to seek screenings due to cost concerns. The bill aligns with overall health initiatives aimed at improving outcomes for individuals at risk of breast cancer by facilitating prompt access to diagnostic services.

Summary

House Bill 2427 aims to enhance insurance coverage provisions for diagnostic examinations related to breast cancer. The bill seeks to ensure that individuals have better access to necessary screenings and diagnostic procedures, which are crucial for early detection and treatment of breast cancer. By mandating that insurance providers cover these examinations, the bill reflects a growing recognition of the importance of preventive healthcare in addressing women’s health issues.

Contention

The discussions surrounding HB 2427 highlight some contention, particularly regarding the implications for insurance companies and the potential for increased costs. Proponents of the bill argue that expanding coverage is a crucial step towards ensuring women's health equity, while opponents express concerns over the financial impact on insurance providers and potential premium increases. Balancing comprehensive healthcare access with the economic realities faced by insurers is a central theme in the debates surrounding this legislation.